O-GlcNAc protein modification stimulates chondrogenesis in vitro and chondrocyte hypertrophy in mouse  by Andrés-Bergós, J. et al.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S150After transfection of PTEN siRNA, the expressions of Col2a1 were increased
and were much more increased when 5% stretch stress was applied in
comparsion with control siRNA (Figure2).
The expressions of Col2a1 were inhibited after exposure to PTEN siRNA
with LY294002 (Figure3).
Conclusions: PTEN is one of the most important tumor suppressor like
p53. We have reported that p53 was increased by shear stress, but PTEN
was not increased. The function of PTEN depends on its abundant
expression. However, p53 acts emergently when DNA is damaged. The role
of PTEN in human chondrocytes might be different from p53.
Col2a1 expression was reported to be regulated via PI3K/Akt pathway. We
conﬁrmed that the expressions of Col2a1 were decreased with attenuation
of Akt phosphorylation when PI3K activity was blocked by LY294002.
Down-regulation of PTEN expression increased Col2a1 expression with
activation of Akt phosphorylation. Therefore, PTEN regulates the expres-
sions of Col2a1 by inhibition of Akt phosphorylation.
In conclusion, PTEN regulates the expressions of typeII collagen in human
chondrocytes. So, PTEN may also have an important role in cartilage repair
via PI3K/Akt pathway in human chondrocytes.
Ă
Ă
Ă
296
O-GLCNAC PROTEIN MODIFICATION STIMULATES CHONDROGENESIS IN
VITRO AND CHONDROCYTE HYPERTROPHY IN MOUSE
J. Andrés-Bergós, L. Tardío, A. Villalvilla, R. Gómez,
G. Herrero-Beaumont, R. Largo. IIS-Fundacion Jimenez Diaz, Madrid, Spain
Purpose: Chondrocyte differentiation that allows endochondral ossiﬁcation
sequentially includes cell proliferation, extracellular matrix synthesis,
cellular hypertrophy, matrix mineralization, vascular invasion andeventually apoptosis, allowing cartilage remodeling into bone. Most of these
processes have been also associated to the development of osteoarthritis.
Insulinameliorates impairedbonegrowthand impairedbonehealingboth in
vitro and in vivo, and is able to induce chondrocyte hypertrophy and growth
plate chondrogenesis, although the speciﬁc molecular mechanisms are
mostly unknown. The addition of O-linkedN-Acetylglucosamine (O-GlcNAc)
to cytoplasmic and nuclear proteins is a post-translational modiﬁcation
implicated in the regulation of a variety of transduction pathways. Our aim
was to investigatewhether insulin-induced chondrocyte hypertrophyoccurs
through amodiﬁcation in the amount of O-GlcNAc glycosylated proteins and
in the expression of the key enzymes of this pathway: O-GlcNAc-transferase
(OGT) and O-GlcNAcase (OGA). Furthermore, we studied if O-GlcNAc-accu-
mulation per se was able to induce pre-hypertrophic chondrocyte differen-
tiation both in vitro and in vivo.
Methods: Pre-chondrogenic ATDC5 cells were cultured in 5% FBS DMEM/
F12. Cell differentiation was induced with 10 mg/ml insulin and studied
during 24 days. To induce the accumulation of O-GlcNAcmodiﬁed proteins,
we employed the speciﬁc OGA inhibitor Thiamet-G (TG). The gene
expression of the differentiation markers collagen X (ColX), PTH receptor
(PTHR), Indian hedgehog protein (IHH), Runx-2, and alkaline phosphatase
(AP) was studied by real time PCR experiments employing TaqMan probes,
while the activity of matrix-metalloproteinase (MMP)-2, -3 and -9 were
measured by zymography. The accumulation of O-GlcNAc modiﬁed
proteins, and the presence of OGT, OGA, extracellular signal-regulated
kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 were studied by
western-blot techniques. The effect of the in vivo accumulationof O-GlcNAc
proteins in the tibial growth plate was studied in 23-day old C57/bl mice
that received 20mg/kg TG during 15 days. Then, animals were euthanized
and tibias were ﬁxed and embedded in parafﬁn for histological studies.
Results: Insulin-induced differentiation paralleled with a gradual increase
in the accumulation of O-GlcNac modiﬁed proteins that was appreciable
since day 3 of differentiation and peaked around day 7-9, together with an
increase in the expression of OGT and OGA. These increases occurred
previously to any modiﬁcation in the gene expression of differentiation
markers, such as ColX, IHH, PTHR1, Runx-2 or AP. Furthermore, O-GlcNAc
accumulation per se induced by OGA inhibition, in the absence of insulin,
was able to induce ATDC5 differentiation measured by an increase in the
expression of differentiation markers. TG treated ATDC5 cells also induced
an increase in the activity of MMP-1,-2 and -9, similar to that evoked by
insulin. In addition, TG induced the activation of p-ERK, p-JNK and p-p38 in
a similar extent to that observed for insulin. The administration of TG to
C57/bl mice induced an accumulation of O-GlcNAc modiﬁed proteins in
different locations, such as brain, liver, muscle and knee joint. Further-
more, TG induced a signiﬁcant expansion in the growth plate height and in
the hypertrophic zone height, in comparison to untreated mice, without
a signiﬁcant modiﬁcation of body weight gain.
Conclusions: TG markedly induced the expression of chondrogenic
markers in ATDC5 cells, as well as activated ERK, JNK and p38. TG also
increased chondrogenic differentiation in vivo. Taken together our results
show that O-GlcNAc glycosylation has chondromodulating activity,
opening new therapeutic targets both in the alterations in endochondral
ossiﬁcation and in osteoarthritis.297
DIFFERENTIAL EFFECTS OF CYCLOOXYGENASE-1 AND -2 SPECIFIC
NSAIDS ON CHONDROGENIC DIFFERENTIATION
M.J. Caron, P.J. Emans, A. Cremers, D.A. Surtel, D. Ophelders, K. Sanen,
L.W. van Rhijn, T.J. Welting. Dept. Orthopaedic Surgery, Maastricht Univ.
Med. Ctr., Maastricht, Netherlands
Purpose: NSAIDs are clinically used to relieve pain and decrease inﬂam-
matory reactions by inhibition of cyclooxygenase (COX)- catalyzed pros-
taglandin (PG) synthesis. As PGs are important fatty acid mediators in bone
and cartilage homeostasis, they thereby may provide a novel opportunity
to inﬂuence cartilage regeneration. In this study we aimed to deﬁne how
different COX-1 or COX-2 speciﬁc NSAIDs inﬂuence chondrocyte extra-
cellular matrix formation.
Methods: ATDC5 cells were differentiated in the presence of different
COX-1 or COX-2 speciﬁc inhibitors. COX-1 or COX-2 speciﬁcity of the
